Ignite Creation Date:
2025-12-25 @ 1:46 AM
Ignite Modification Date:
2026-02-28 @ 3:47 AM
Study NCT ID:
NCT03641794
Status:
UNKNOWN
Last Update Posted:
2019-08-01
First Post:
2018-08-15
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Indoleamine 2,3-Dioxygenase (IDO) Inhibitor in Healthy Volunteers
Sponsor:
Jiangxi Qingfeng Pharmaceutical Co. Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-09-07
Start Date Type:
ACTUAL
Primary Completion Date:
2019-05-13
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-07-31
Completion Date Type:
ESTIMATED
First Submit Date:
2018-08-15
First Submit QC Date:
None
Study First Post Date:
2018-08-22
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-07-31
Last Update Post Date:
2019-08-01
Last Update Post Date Type:
ACTUAL